blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0695185

EP0695185 - USE OF ADENOSINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PULMONARY INFLAMMATORY REACTIONS [Right-click to bookmark this link]
Former [1996/06]NEW METHOD OF TREATMENT
[1998/45]
StatusNo opposition filed within time limit
Status updated on  11.08.2000
Database last updated on 02.11.2024
Most recent event   Tooltip11.08.2000No opposition filed within time limitpublished on 27.09.2000 [2000/39]
Applicant(s)For all designated states
ITEM DEVELOPMENT AB
Box 65
S-182 71 Stocksund / SE
[1996/06]
Inventor(s)01 / SOLLEVI, Alf
Carl Larssons väg 12
S-161 55 Bromma / SE
[1996/06]
Representative(s)Fogelberg, Lennart, et al
Allied Attorneys Chemical AB, Box 24107
104 51 Stockholm / SE
[N/P]
Former [1996/06]Fogelberg, Lennart, et al
Allied Attorneys Chemical AB, Box 27097
S-102 51 Stockholm / SE
Application number, filing date94903224.703.01.1994
[1996/06]
WO1994SE00001
Priority number, dateSE1993000132421.04.1993         Original published format: SE 9301324
[1996/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9404017
Date:03.03.1994
[1994/06]
Type: A1 Application with search report 
No.:EP0695185
Date:07.02.1996
[1996/06]
Type: B1 Patent specification 
No.:EP0695185
Date:13.10.1999
Language:EN
[1999/41]
Search report(s)International search report - published on:SE01.09.1994
ClassificationIPC:A61K31/70
[1996/06]
CPC:
A61K31/70 (EP,US); A61P11/00 (EP); A61P29/00 (EP);
A61P31/04 (EP); A61P31/12 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   NL,   SE [1996/06]
TitleGerman:VERWENDUNG VON ADENOSIN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG ENTZÜDLICHER REAKTIONEN DER LUNGE[1998/45]
English:USE OF ADENOSINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PULMONARY INFLAMMATORY REACTIONS[1998/45]
French:UTILISATION D'ADENOSINE POUR LA FABRICATION D'UN MEDICAMENT POUR LE TRAITEMENT DES REACTIONS INFLAMMATOIRES PULMONAIRES[1998/45]
Former [1996/06]NEUES BEHANDLUNGSVERFAHREN
Former [1996/06]NEW METHOD OF TREATMENT
Former [1996/06]NOUVEAU PROCEDE DE TRAITEMENT
Entry into regional phase05.10.1995National basic fee paid 
05.10.1995Designation fee(s) paid 
05.10.1995Examination fee paid 
Examination procedure04.11.1994Request for preliminary examination filed
International Preliminary Examining Authority: SE
05.10.1995Examination requested  [1996/06]
18.07.1998Request for accelerated examination filed
09.02.1999Despatch of communication of intention to grant (Approval: Yes)
09.02.1999Decision about request for accelerated examination - accepted: Yes
04.03.1999Communication of intention to grant the patent
17.05.1999Fee for grant paid
17.05.1999Fee for publishing/printing paid
Opposition(s)14.07.2000No opposition filed within time limit [2000/39]
Fees paidRenewal fee
28.02.1996Renewal fee patent year 03
24.01.1997Renewal fee patent year 04
28.01.1998Renewal fee patent year 05
29.01.1999Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.199603   M06   Fee paid on   28.02.1996
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US5104859  (SOLLEVI ALF [SE])
 [Y]  - Surgery, Volume 94, July 1983, PATRICK J. BROE et al., "Aspiration Pneumonia: Treatment with Pulmonary Vasodilators", page 95 - page 99.
 [A]  - Med. Microbiol. Immunol., Volume 165, 1978, MICHAEL G. GABRIGE et al., "Role of Adenine in the Pathogenesis of Mycoplasma Pneumoniae Infections of Tracheal Epithelium", page 43 - page 45.
 [A]  - Journal of Applied Physiology, Volume 71, 1991, JOANN D. BRADLEY et al., "Adenosine Prevents Phorbol Ester Injury in Rabbit Lungs: Role of Leukotrienes and TNF", page 1949 - page 1955.
by applicantUS5104859
    - "Adenosine receptors in the central nervous system: Structure-activity relationships for agonists and antagonism", DALY, J.W., Purines: Pharmacological and physiological roles, MACMILLAN, (1985), pages 5 - 15
    - BELARDINELLI, L.; LINDEN, J.; BERNE, R., "The cardiac effects of adenosine", PROG. CARDIO DIS, (1989), vol. 32, doi:doi:10.1016/0033-0620(89)90015-7, page 73, XP026327200

DOI:   http://dx.doi.org/10.1016/0033-0620(89)90015-7
    - WARD, P. ET AL., "Functional consequences of interactions between human neutrophils and ATP, ATPTS, and Adenosine", ANN NY ACAD SCI, (1990), vol. 603, pages 108 - 19
    - CRONSTEIN, B.N.; KRAMER, S.B.; WEISSMANN, G. ET AL., "Adenosine: a physiological modulator of superoxide anion generation by human neutrophils", J EXP MED, (1983), vol. 158, pages 1160 - 1177
    - CRONSTEIN, B.N.; LEVIN, R.I.; BELANOFF, J. ET AL., "Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells", J CLIN INVEST, (1986), vol. 78, pages 760 - 770
    - "Clinical studies on the effect of adenosine", SOLLEVI, A., Role of adenosine nucleotides in the biological system, ELSEVIER SCI PUBL VB, (1991), pages 525 - 537
    - ELY, S.W.; BERNE, R.M., "Protective effects of adenosine in myocardial ischemia", CIRCULATION, (1992), pages 893 - 904
    - CHRISTOS, J. ET AL., "Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period", CIRCULATION, (1991), vol. 83, pages 237 - 247
    - BOEHM, D.H. ET AL., "Adenosine cardioplegia: Reducing reperfusion injury of the ischaemic myocardium", EUR J CARDIO-THORAC SURG, (1991), vol. 5, pages 542 - 545
    - NORTON, E. D. ET AL., "The effect of intravenous infusions of selective adenosine AI-receptor and A2-receptor agonists on myocardial reperfusion injury", A M HEART J, (1992), vol. 123, doi:doi:10.1016/0002-8703(92)90643-A, page 332, XP022945400

DOI:   http://dx.doi.org/10.1016/0002-8703(92)90643-A
    - ELY, S.W.; BERNE, R.M., "Protective effects of adenosine in myocardial ischemia", CIRCULATION, (1992), vol. 85, pages 893 - 904
    - KARASAWA, A.; ROCHESTER, J.A.; LEFER, A.M., "Effects of adenosine, and adenosine Ai-antagonist, and their combination in splanchnic occlusion shock in rats", CIRCULATORY SHOCK, (1992), vol. 36, pages 154 - 161
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.